Zakaria Einbeigi

3.0k total citations
54 papers, 1.0k citations indexed

About

Zakaria Einbeigi is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Zakaria Einbeigi has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 25 papers in Cancer Research and 15 papers in Genetics. Recurrent topics in Zakaria Einbeigi's work include BRCA gene mutations in cancer (15 papers), Cancer Treatment and Pharmacology (15 papers) and Breast Cancer Treatment Studies (15 papers). Zakaria Einbeigi is often cited by papers focused on BRCA gene mutations in cancer (15 papers), Cancer Treatment and Pharmacology (15 papers) and Breast Cancer Treatment Studies (15 papers). Zakaria Einbeigi collaborates with scholars based in Sweden, United States and Denmark. Zakaria Einbeigi's co-authors include Per Karlsson, Khalil Helou, Anikó Kovács, Toshima Z. Parris, Emman Shubbar, Szilárd Nemes, Shahin Hajizadeh, K. Gunnarsdóttir, Thomas Hatschek and Margareta Nordling and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Zakaria Einbeigi

54 papers receiving 1.0k citations

Peers

Countries citing papers authored by Zakaria Einbeigi

Since Specialization

Citations

This map shows the geographic impact of Zakaria Einbeigi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zakaria Einbeigi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zakaria Einbeigi more than expected).

Fields of papers citing papers by Zakaria Einbeigi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zakaria Einbeigi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zakaria Einbeigi. The network helps show where Zakaria Einbeigi may publish in the future.

Co-authorship network of co-authors of Zakaria Einbeigi

This figure shows the co-authorship network connecting the top 25 collaborators of Zakaria Einbeigi. A scholar is included among the top collaborators of Zakaria Einbeigi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zakaria Einbeigi. Zakaria Einbeigi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	339TiP A randomized trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE) 2024 ·Annals of Oncology ·(unknown), (unknown), Andreas Karakatsanis, Anne Andersson, (unknown), (unknown), Zakaria Einbeigi, (unknown), Fredrika Killander, Barbro Linderholm, (unknown), Antonios Valachis, Jonas Bergh, Guillermo Villacampa, (unknown), Mats Hellström, (unknown), Alexios Matikas	1
2	Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer 2023 ·BMC Cancer ·Anna Öfverholm, Therese Törngren, Anna Rosén, Brita Arver, Zakaria Einbeigi, Karin Haraldsson, Anne Kinhult Ståhlbom, Ekaterina Kuchinskaya, Annika Lindblom, Beatrice Melin, Ylva Paulsson-Karlsson, Marie Stenmark‐Askmalm, Emma Tham, Anna von Wachenfeldt, Anders Kvist, Åke Borg, Hans Ehrencrona	5
3	Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up 2021 ·The Breast ·(unknown), Helena Fohlin, Per Albertsson, L-G Arnesson, Zakaria Einbeigi, Erik Holmberg, Anna Nordenskjöld, Bo Nordenskjöld, Per Karlsson, Barbro Linderholm	22
4	Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer (T1abN0) 2020 ·JNCI Cancer Spectrum ·(unknown), Jonas Höijer, Linnea Widman, Johan Ahlgren, Lars-Gunnar Arnesson, Zakaria Einbeigi, Marie Klintman, (unknown), Malin Sund, Irma Fredriksson, Jonas Bergh, (unknown)	3
5	Immune gene expression and response to chemotherapy in advanced breast cancer 2018 ·British Journal of Cancer ·(unknown), Theodoros Foukakis, John Lövrot, Alexios Matikas, Ioannis Zerdes, Julie Lorent, Nicholas P. Tobin, Takayuki Suzuki, Søren Brage, Lena Carlsson, Zakaria Einbeigi, Barbro Linderholm, Niklas Loman, Martin Malmberg, Mårten Fernö, Lambert Skoog, Jonas Bergh, Thomas Hatschek	37
6	PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients 2017 ·Clinical Cancer Research ·Nicholas P. Tobin, Arian Lundberg, Linda S. Lindström, J. Chuck Harrell, Theodoros Foukakis, Lena Carlsson, Zakaria Einbeigi, Barbro Linderholm, Niklas Loman, Martin Malmberg, Mårten Fernö, Kamila Czene, Charles M. Perou, Jonas Bergh, Thomas Hatschek	10
7	Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer 2015 ·Clinical Cancer Research ·Siker Kimbung, Ida Johansson, Anna Danielsson, Srinivas Veerla, Søren Brage, Marianne Frostvik Stolt, Lambert Skoog, Lena Carlsson, Zakaria Einbeigi, Elisabet Lidbrink, Barbro Linderholm, Niklas Loman, Per-Olof Malmström, Martin Söderberg, Thomas Walz, Mårten Fernö, Thomas Hatschek, Ingrid Hedenfalk	36
8	No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study 2015 ·Annals of Oncology ·Anna Nordenskjöld, Helena Fohlin, Per Albertsson, (unknown), (unknown), Zakaria Einbeigi, Erik Holmberg, Bo Nordenskjöld, Per Karlsson	26
9	Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel 2013 ·The Breast ·Barbro Linderholm, Elisabet Lidbrink, Eva Tallroth, Zakaria Einbeigi, Harry Svensson, Anna von Wachenfeldt, Bo Norberg, Lena Carlsson, Mia Olsson, Jonas Bergh, N. Wilking, Thomas Hatschek	5
10	Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome 2013 ·BMC Cancer ·Emman Shubbar, Anikó Kovács, Shahin Hajizadeh, Toshima Z. Parris, Szilárd Nemes, K. Gunnarsdóttir, Zakaria Einbeigi, Per Karlsson, Khalil Helou	277
11	Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy 2013 ·Medical Oncology ·Takayuki Suzuki, Lennart Blomqvist, Thomas Hatschek, Lena Carlsson, Zakaria Einbeigi, Barbro Linderholm, Birgitta Lindh, Niklas Loman, Martin Malmberg, Samuel Rotstein, Martin Söderberg, (unknown), Thomas Walz, Gunnar Åström, Hirofumi Fujii, Hans Jacobsson, Bengt Glimelius	6
12	Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial 2011 ·Breast Cancer Research and Treatment ·Thomas Hatschek, Lena Carlsson, Zakaria Einbeigi, Elisabet Lidbrink, Barbro Linderholm, Birgitta Lindh, Niklas Loman, Martin Malmberg, S Rotstein, Martin Söderberg, M. Sundquist, Thomas Walz, Mats Hellström, Harry Svensson, Gunnar Åström, Yvonne Brandberg, John Carstensen, Mårten Fernö, Jonas Bergh	23
13	BRCA1gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer – a population based study from the Western Sweden Health Care region 2010 ·Acta Oncologica ·Zakaria Einbeigi, Charlotta Enerbäck, Arne Wallgren, Margareta Nordling, Per Karlsson	8
14	Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine) 2010 ·Breast Cancer Research and Treatment ·(unknown), Zakaria Einbeigi, Hemming Johansson, Thomas Hatschek, Yvonne Brandberg	12
15	Psychological Reactions to Progression of Metastatic Breast Cancer-An Interview Study 2008 ·Cancer Nursing ·(unknown), Yvonne Brandberg, Zakaria Einbeigi, Thomas Hatschek, Karin Ahlberg	17
16	A hypothesis-generating search for new genetic breast cancer syndromes a national study in 803 Swedish families 2007 ·Hereditary Cancer in Clinical Practice ·Anna von Wachenfeldt, Annika Lindblom, (unknown), Henrik Grönberg, Zakaria Einbeigi, Richard Rosenquist, (unknown), Lennart Iselius	6
17	Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden 2006 ·Familial Cancer ·Zakaria Einbeigi, Annika Bergman, Jeanne M. Meis‐Kindblom, (unknown), Cecilia Bjursell, Tommy Martinsson, Lars‐Gunnar Kindblom, Jan Wahlström, Arne Wallgren, Margareta Nordling, Per Karlsson	12
18	A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques 2005 ·Familial Cancer ·Annika Bergman, (unknown), Yvonne Engwall, Eva Lagberg Arkblad, Kerstin Berg, Zakaria Einbeigi, Tommy Martinsson, Jan Wahlström, Per Karlsson, Margareta Nordling	25
19	Hereditary breast and ovarian cancer in western Sweden with a special focus on BRCA1 3171ins5 mutation 2004 ·Gothenburg University Publications Electronic Archive (Gothenburg University) ·Zakaria Einbeigi	1
20	Prognosis and clinical presentation of BRCA2-associated breast cancer 2000 ·European Journal of Cancer ·Niklas Loman, Óskar Þór Jóhannsson, Pär‐Ola Bendahl, Niklas Dahl, Zakaria Einbeigi, Anne‐Marie Gerdes, Åke Borg, Håkan Olsson	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact